Monday, October 27, 2014

Merck Sales Down 4%; Profit Beats Forecasts

The pharmaceutical company’s earnings beat expectations, however, helped by sales of the diabetes drug Januvia and revenue in emerging markets.


via NYT > Health http://ift.tt/1tBB3vQ








via All Health and Fitness http://ift.tt/1zClzLs

No comments:

Post a Comment